Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/32927
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSeferovic, Petar M.-
dc.contributor.authorFragasso, Gabriele-
dc.contributor.authorPetrie, Mark-
dc.contributor.authorMULLENS, Wilfried-
dc.contributor.authorFerrari, Roberto-
dc.contributor.authorThum, Thomas-
dc.contributor.authorBauersachs, Johann-
dc.contributor.authorAnker, Stefan D.-
dc.contributor.authorRay, Robin-
dc.contributor.authorCavusoglu, Yuksel-
dc.contributor.authorPolovina, Marija-
dc.contributor.authorMetra, Marco-
dc.contributor.authorAmbrosio, Giuseppe-
dc.contributor.authorPrasad, Krishna-
dc.contributor.authorSeferovic, Jelena-
dc.contributor.authorJhund, Pardeep S.-
dc.contributor.authorDattilo, Giuseppe-
dc.contributor.authorCelutkiene, Jelena-
dc.contributor.authorPiepoli, Massimo-
dc.contributor.authorMoura, Brenda-
dc.contributor.authorChioncel, Ovidiu-
dc.contributor.authorBen Gal, Tuvia-
dc.contributor.authorHeymans, Stephane-
dc.contributor.authorJaarsma, Tiny-
dc.contributor.authorHill, Loreena-
dc.contributor.authorLopatin, Yuri-
dc.contributor.authorLyon, Alexander R.-
dc.contributor.authorPonikowski, Piotr-
dc.contributor.authorLainscak, Mitja-
dc.contributor.authorJankowska, Ewa-
dc.contributor.authorMueller, Christian-
dc.contributor.authorCosentino, Francesco-
dc.contributor.authorLund, Lars H.-
dc.contributor.authorFilippatos, Gerasimos S.-
dc.contributor.authorRuschitzka, Frank-
dc.contributor.authorCoats, Andrew J. S.-
dc.contributor.authorRosano, Giuseppe M. C.-
dc.date.accessioned2020-12-15T10:53:33Z-
dc.date.available2020-12-15T10:53:33Z-
dc.date.issued2020-
dc.date.submitted2020-12-15T09:49:37Z-
dc.identifier.citationEuropean journal of heart failure, 22 (11) , p. 1984 -1986-
dc.identifier.urihttp://hdl.handle.net/1942/32927-
dc.description.abstractThe Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued a position paper on the role of sodium-glucose co-transporter 2 (SGLT2) inhibitors in heart failure (HF). The present document provides an update of the position paper, based of new clinical trial evidence. Accordingly, the following recommendations are given: center dot Canagliflozin, dapagliflozin empagliflozin, or ertugliflozin have consistently demonstrated to be effective for the prevention of HF hospitalization in patients with type 2 diabetes mellitus and established cardiovascular disease or at high cardiovascular risk. The specifically listed agents are recommended. center dot Dapagliflozin or empagliflozin are recommended to reduce the combined risk of HF hospitalization and cardiovascular death in symptomatic patients with HF and reduced ejection fraction, already receiving guideline-directed medical therapy, regardless of the presence of type 2 diabetes mellitus.-
dc.language.isoen-
dc.publisherWILEY-
dc.rights2020 European Society of Cardiology-
dc.subject.otherHeart failure-
dc.subject.otherSodium&#8211-
dc.subject.otherglucose co&#8208-
dc.subject.othertransporter 2 inhibitors-
dc.subject.otherType 2 diabetes mellitus-
dc.subject.otherCardiovascular outcomes-
dc.subject.otherRenal function-
dc.titleHeart Failure Association of the EuropeanSociety of Cardiology update onsodium–glucose co-transporter 2 inhibitorsin heart failure-
dc.typeJournal Contribution-
dc.identifier.epage1986-
dc.identifier.issue11-
dc.identifier.spage1984-
dc.identifier.volume22-
local.format.pages4-
local.bibliographicCitation.jcatA1-
dc.description.notesSeferovic, PM (corresponding author), Univ Belgrade, Fac Med, Heart Failure Soc Serbia, 8 Koste Todorovica, Belgrade 11000, Serbia.-
dc.description.notesseferovic.petar@gmail.com-
dc.description.otherSeferovic, PM (corresponding author), Univ Belgrade, Fac Med, Heart Failure Soc Serbia, 8 Koste Todorovica, Belgrade 11000, Serbia. seferovic.petar@gmail.com-
local.publisher.place111 RIVER ST, HOBOKEN 07030-5774, NJ USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1002/ejhf.2026-
dc.identifier.isiWOS:000585897600001-
dc.contributor.orcidPiepoli, Massimo/0000-0003-1124-234X-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Seferovic, Petar M.; Polovina, Marija; Seferovic, Jelena] Univ Belgrade, Fac Med, Belgrade, Serbia.-
local.description.affiliation[Seferovic, Petar M.] Serbian Acad Arts & Sci, Belgrade, Serbia.-
local.description.affiliation[Fragasso, Gabriele] Univ Hosp San Raffaele, Heart Failure Unit, Clin Cardiol, Milan, Italy.-
local.description.affiliation[Petrie, Mark] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.-
local.description.affiliation[Mullens, Wilfried] Hasselt Univ, Fac Med & Life Sci, BIOMED Biomed Res Inst, Diepenbeek, Belgium.-
local.description.affiliation[Mullens, Wilfried] Ziekenhuis Oost, Dept Cardiol, Genk, Belgium.-
local.description.affiliation[Ferrari, Roberto] Univ Hosp Ferrara, Dept Cardiol, Cotignola, Italy.-
local.description.affiliation[Ferrari, Roberto] Univ Hosp Ferrara, LTTA Ctr, Cotignola, Italy.-
local.description.affiliation[Ferrari, Roberto] Maria Cecilia Hosp, ES Hlth Sci Fdn, GVM Care & Res, Cotignola, Italy.-
local.description.affiliation[Thum, Thomas] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany.-
local.description.affiliation[Bauersachs, Johann] Med Sch Hannover, Dept Cardiol & Angiol, Hannover, Germany.-
local.description.affiliation[Anker, Stefan D.] Berlin Inst Hlth Ctr Regenerat Therapies BCRT, Dept Cardiol CVK, Berlin, Germany.-
local.description.affiliation[Anker, Stefan D.] Charit Univ Med Berlin, German Ctr Cardiovasc Res DZHK Partner Site Berli, Berlin, Germany.-
local.description.affiliation[Ray, Robin] Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon, England.-
local.description.affiliation[Cavusoglu, Yuksel] Eskisehir Osmangazi Univ, Fac Med, Dept Cardiol, Eskisehir, Turkey.-
local.description.affiliation[Polovina, Marija] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia.-
local.description.affiliation[Metra, Marco] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Cardiol, Brescia, Italy.-
local.description.affiliation[Ambrosio, Giuseppe] Univ Perugia, Div Cardiol, Perugia, Italy.-
local.description.affiliation[Prasad, Krishna] United Kingdom Med & Healthcare Prod Regulatory A, London, England.-
local.description.affiliation[Seferovic, Jelena] Clin Ctr, Clin Endocrinol Diabet & Metab Disorders, Belgrade, Serbia.-
local.description.affiliation[Jhund, Pardeep S.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.-
local.description.affiliation[Dattilo, Giuseppe] Univ Messina, Dept Clin & Expt Med, Cardiol Unit, Messina, Italy.-
local.description.affiliation[Celutkiene, Jelena] Vilnius Univ, Fac Med, Inst Clin Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.-
local.description.affiliation[Piepoli, Massimo] Guglielmo da Saliceto Hosp, Heart Failure Unit, Cardiol, Piacenza, Italy.-
local.description.affiliation[Moura, Brenda] Univ Porto, Fac Med, Hosp Forcas Armadas & Cintesis, Porto, Portugal.-
local.description.affiliation[Chioncel, Ovidiu] Univ Med & Pharm Carol Davila, Bucharest, Romania.-
local.description.affiliation[Chioncel, Ovidiu] Emergency Inst Cardiovasc Dis Prof CC Iliescu, Bucharest, Romania.-
local.description.affiliation[Ben Gal, Tuvia] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Dept Cardiol, Tel Aviv, Israel.-
local.description.affiliation[Heymans, Stephane] Maastricht Univ, Cardiovasc Res Inst Maastricht, Med Ctr, Maastricht, Netherlands.-
local.description.affiliation[Jaarsma, Tiny] Linkoping Univ, Fac Hlth Sci, Dept Social & Welf Studies, Linkoping, Sweden.-
local.description.affiliation[Hill, Loreena] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland.-
local.description.affiliation[Lopatin, Yuri] Volgograd State Med Univ, Reg Cardiol Ctr Volgograd, Volgograd, Russia.-
local.description.affiliation[Lyon, Alexander R.] Imperial Coll London, Natl Heart & Lung Inst, London, England.-
local.description.affiliation[Lyon, Alexander R.] Royal Brompton Hosp, London, England.-
local.description.affiliation[Ponikowski, Piotr; Jankowska, Ewa] Wroclaw Med Univ, Fac Hlth Sci, Ctr Heart Dis, Wroclaw, Poland.-
local.description.affiliation[Lainscak, Mitja] Gen Hosp Murska Sobota, Dept Internal Med, Dept Res & Educ, Murska Sobota, Murska Sobota, Slovenia.-
local.description.affiliation[Lainscak, Mitja] Univ Ljubljana, Fac Med, Ljubljana, Slovenia.-
local.description.affiliation[Mueller, Christian] Univ Hosp Basel, Cardiovasc Res Inst Basel, Dept Cardiol, Basel, Switzerland.-
local.description.affiliation[Cosentino, Francesco] Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden.-
local.description.affiliation[Cosentino, Francesco] Karolinska Univ Hosp, Stockholm, Sweden.-
local.description.affiliation[Lund, Lars H.] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Stockholm, Sweden.-
local.description.affiliation[Lund, Lars H.] Karolinska Univ Hosp, Heart & Vasc Theme, Stockholm, Sweden.-
local.description.affiliation[Filippatos, Gerasimos S.] Natl & Kapodistrian Univ Athens, Univ Hosp Attikon, Sch Med, Athens, Greece.-
local.description.affiliation[Ruschitzka, Frank] Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland.-
local.description.affiliation[Coats, Andrew J. S.] IRCCS San Raffaele Pisana, Ctr Clin & Expt Med, Pharmacol, Rome, Italy.-
local.description.affiliation[Rosano, Giuseppe M. C.] IRCCS San Raffaele Pisana, Dept Med Sci, Rome, Italy.-
local.uhasselt.internationalyes-
item.contributorSeferovic, Petar M.-
item.contributorFragasso, Gabriele-
item.contributorPetrie, Mark-
item.contributorMULLENS, Wilfried-
item.contributorFerrari, Roberto-
item.contributorThum, Thomas-
item.contributorBauersachs, Johann-
item.contributorAnker, Stefan D.-
item.contributorRay, Robin-
item.contributorCavusoglu, Yuksel-
item.contributorPolovina, Marija-
item.contributorMetra, Marco-
item.contributorAmbrosio, Giuseppe-
item.contributorPrasad, Krishna-
item.contributorSeferovic, Jelena-
item.contributorJhund, Pardeep S.-
item.contributorDattilo, Giuseppe-
item.contributorCelutkiene, Jelena-
item.contributorPiepoli, Massimo-
item.contributorMoura, Brenda-
item.contributorChioncel, Ovidiu-
item.contributorBen Gal, Tuvia-
item.contributorHeymans, Stephane-
item.contributorJaarsma, Tiny-
item.contributorHill, Loreena-
item.contributorLopatin, Yuri-
item.contributorLyon, Alexander R.-
item.contributorPonikowski, Piotr-
item.contributorLainscak, Mitja-
item.contributorJankowska, Ewa-
item.contributorMueller, Christian-
item.contributorCosentino, Francesco-
item.contributorLund, Lars H.-
item.contributorFilippatos, Gerasimos S.-
item.contributorRuschitzka, Frank-
item.contributorCoats, Andrew J. S.-
item.contributorRosano, Giuseppe M. C.-
item.accessRightsOpen Access-
item.fullcitationSeferovic, Petar M.; Fragasso, Gabriele; Petrie, Mark; MULLENS, Wilfried; Ferrari, Roberto; Thum, Thomas; Bauersachs, Johann; Anker, Stefan D.; Ray, Robin; Cavusoglu, Yuksel; Polovina, Marija; Metra, Marco; Ambrosio, Giuseppe; Prasad, Krishna; Seferovic, Jelena; Jhund, Pardeep S.; Dattilo, Giuseppe; Celutkiene, Jelena; Piepoli, Massimo; Moura, Brenda; Chioncel, Ovidiu; Ben Gal, Tuvia; Heymans, Stephane; Jaarsma, Tiny; Hill, Loreena; Lopatin, Yuri; Lyon, Alexander R.; Ponikowski, Piotr; Lainscak, Mitja; Jankowska, Ewa; Mueller, Christian; Cosentino, Francesco; Lund, Lars H.; Filippatos, Gerasimos S.; Ruschitzka, Frank; Coats, Andrew J. S. & Rosano, Giuseppe M. C. (2020) Heart Failure Association of the EuropeanSociety of Cardiology update onsodium–glucose co-transporter 2 inhibitorsin heart failure. In: European journal of heart failure, 22 (11) , p. 1984 -1986.-
item.validationecoom 2021-
item.fulltextWith Fulltext-
crisitem.journal.issn1388-9842-
crisitem.journal.eissn1879-0844-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
ejhf.2026.pdfPublished version488.86 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.